test

Nathan Fischel

@Dafna Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$423.312MTotal holdings84
Assets growth rate1.14%Assets growth rate (2-Q avg)-1.79%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Dafna Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 84 positions.

Assets under management

The assets under management (AUM) of Dafna Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 423.312M in assets, with a quarterly growth rate of 1.14% and a 2-quarter average growth rate of -1.79%. The portfolio is managed by Nathan Fischel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RVMDRevolution Medicines Inc
Recent Activity
Increased 1.2%
5.55%
$23.491M
517,994 shares@ $45.36 avg price
MRUSMerus N V
Recent Activity
Increased 0.77%
4.87%
$20.612M
412,573 shares@ $49.96 avg price
ATRCAtricure Inc
Recent Activity
Increased 0.4%
4.26%
$17.993M
641,673 shares@ $28.05 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 11.66%
3.53%
$14.934M
471,410 shares@ $31.69 avg price
ASNDAscendis Pharma A S
Recent Activity
Increased 10.63%
3.16%
$13.374M
89,572 shares@ $149.31 avg price
BPMCBlueprint Medicines Corp
Recent Activity
Increased 16.23%
2.67%
$11.263M
121,763 shares@ $92.51 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
Increased 12.59%
2.47%
$10.453M
750,363 shares@ $13.94 avg price
KROSKeros Therapeutics Inc
Recent Activity
Increased 8.86%
1.02%
$4.283M
73,754 shares@ $58.08 avg price
RCUSArcus Biosciences Inc
Recent Activity
Increased 1.39%
0.93%
$3.925M
256,717 shares@ $15.3 avg price
ALLOAllogene Therapeutics Inc
Recent Activity
Increased 73.55%
0.7%
$2.94M
1.05M shares@ $2.8 avg price